Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes in Pseudoxanthoma elasticum patients can indicate the severity of related health issues.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

The new measure helps understand the personal and emotional impact of hair loss in alopecia areata patients.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

A new tool helps lupus patients and doctors better track symptoms and quality of life.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Multiparametric ultrasound is a useful non-invasive tool for assessing scalp conditions in alopecia areata patients.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

The Pemphigus Disease Area Index and Autoimmune Bullous Skin Disorder Intensity Score are the best tools for assessing pemphigus severity.

The goal is to create a tool for patients to report their experiences with various hair and scalp disorders.

The BIOMAP glossary standardizes data to improve research on atopic dermatitis and psoriasis.

The Facial Psoriasis Log-based Area and Severity Index is a more effective way to measure improvements in facial psoriasis than the traditional method.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

A 30-year-old man with rare skin conditions improved with antibiotics and surgery, hinting at a link to rosacea.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

The Turkish version of the MAIA-2 Scale is valid and reliable for patients at a dermatology clinic.

Psoriasis patients experience moderate functional impairment related to disease severity and less satisfaction.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

The study created a 27-item measure to assess the impact of skin diseases.

PRAME helps distinguish between benign and malignant skin cells in most cases.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Pityriasis rubra pilaris significantly worsens quality of life more than many other health conditions.